Abstract 4718: ABBV-075, a novel BET family bromodomain inhibitor, represents a promising therapeutic agent for a broad spectrum of cancer indicationsAparna V. Sarthy, Yu Shen, Daniel H. Albert et al.|Cancer Research|2016Cited by 10